Phage Display--a Powerful Technique for Immunotherapy: 1. Introduction and Potential of Therapeutic Applications

Overview

Journal Hum Vaccin Immunother

Specialty Allergy & Immunology

Date 2012 Aug 22

PMID 22906939

Citations 82

Authors

Justyna Bazan

Ireneusz Calkosinski

Andrzej Gamian

Affiliations

Soon will be listed here.

Abstract

One of the most effective molecular diversity techniques is phage display. This technology is based on a direct linkage between phage phenotype and its encapsulated genotype, which leads to presentation of molecule libraries on the phage surface. Phage display is utilized in studying protein-ligand interactions, receptor binding sites and in improving or modifying the affinity of proteins for their binding partners. Generating monoclonal antibodies and improving their affinity, cloning antibodies from unstable hybridoma cells and identifying epitopes, mimotopes and functional or accessible sites from antigens are also important advantages of this technology. Techniques originating from phage display have been applied to transfusion medicine, neurological disorders, mapping vascular addresses and tissue homing of peptides. Phages have been applicable to immunization therapies, which may lead to development of new tools used for treating autoimmune and cancer diseases. This review describes the phage display technology and presents the recent advancements in therapeutic applications of phage display.

Citing Articles

Development of ELISA Using Phage-Displayed Stx2 Mini-Body for Detection of STEC Antigen in Field Farming Pig Samples.

Hur J, Jung H, Park J, Maharjan A, Park S Microorganisms. 2025; 13(2).

PMID: 40005748 PMC: 11858614. DOI: 10.3390/microorganisms13020382.

Current Review of Monoclonal Antibody Therapeutics in Small Animal Medicine.

Wang J, Zhou X, Elazab S, Huang J, Hsu W Animals (Basel). 2025; 15(4).

PMID: 40002954 PMC: 11852019. DOI: 10.3390/ani15040472.

Isolation and Characterization of Antibodies Against Vascular Cell Adhesion Molecule-1 Reveals Putative Role for Ig-like Domains 2 and 3 in Cell-to-Cell Interaction.

Perera B, Wu Y, Pickett J, Panagides N, Barretto F, Fercher C Int J Mol Sci. 2025; 25(24.

PMID: 39769411 PMC: 11678699. DOI: 10.3390/ijms252413650.

The Evolution of Phage Therapy: A Comprehensive Review of Current Applications and Future Innovations.

Sahoo K, Meshram S Cureus. 2024; 16(9):e70414.

PMID: 39473661 PMC: 11519598. DOI: 10.7759/cureus.70414.

Generation of a Biotin-Tagged Dual-Display Phage.

De Plano L, Oddo S, Bikard D, Caccamo A, Conoci S Cells. 2024; 13(20.

PMID: 39451214 PMC: 11506469. DOI: 10.3390/cells13201696.

References

Kaplan G, Gershoni J . A general insert label for peptide display on chimeric filamentous bacteriophages. Anal Biochem. 2011; 420(1):68-72. PMC: 7094602. DOI: 10.1016/j.ab.2011.08.050. View

Kim Y, Lillo A, Steiniger S, Liu Y, Ballatore C, Anichini A . Targeting heat shock proteins on cancer cells: selection, characterization, and cell-penetrating properties of a peptidic GRP78 ligand. Biochemistry. 2006; 45(31):9434-44. DOI: 10.1021/bi060264j. View

Chan C, Chan A, Lim A, Hanson B . Comparison of the efficiency of antibody selection from semi-synthetic scFv and non-immune Fab phage display libraries against protein targets for rapid development of diagnostic immunoassays. J Immunol Methods. 2011; 373(1-2):79-88. PMC: 7094349. DOI: 10.1016/j.jim.2011.08.005. View

Haubner R, Wester H, Burkhart F, Senekowitsch-Schmidtke R, Weber W, Goodman S . Glycosylated RGD-containing peptides: tracer for tumor targeting and angiogenesis imaging with improved biokinetics. J Nucl Med. 2001; 42(2):326-36. View

Arap W, Haedicke W, Bernasconi M, Kain R, Rajotte D, Krajewski S . Targeting the prostate for destruction through a vascular address. Proc Natl Acad Sci U S A. 2002; 99(3):1527-31. PMC: 122224. DOI: 10.1073/pnas.241655998. View

Hetian L, Ping A, Shumei S, Xiaoying L, Luowen H, Jian W . A novel peptide isolated from a phage display library inhibits tumor growth and metastasis by blocking the binding of vascular endothelial growth factor to its kinase domain receptor. J Biol Chem. 2002; 277(45):43137-42. DOI: 10.1074/jbc.M203103200. View

Garet E, Cabado A, Vieites J, Gonzalez-Fernandez A . Rapid isolation of single-chain antibodies by phage display technology directed against one of the most potent marine toxins: Palytoxin. Toxicon. 2010; 55(8):1519-26. DOI: 10.1016/j.toxicon.2010.03.005. View

Askoxylakis V, Zitzmann S, Mier W, Graham K, Kramer S, von Wegner F . Preclinical evaluation of the breast cancer cell-binding peptide, p160. Clin Cancer Res. 2005; 11(18):6705-12. DOI: 10.1158/1078-0432.CCR-05-0432. View

Rubenwolf S, Niewohner J, Meyer E, Petit-Frere C, Rudert F, Hoffmann P . Functional proteomics using chromophore-assisted laser inactivation. Proteomics. 2002; 2(3):241-6. DOI: 10.1002/1615-9861(200203)2:3<241::aid-prot241>3.0.co;2-7. View

10.

Ishii K, Lin C, Siegel D, Stanley J . Isolation of pathogenic monoclonal anti-desmoglein 1 human antibodies by phage display of pemphigus foliaceus autoantibodies. J Invest Dermatol. 2007; 128(4):939-48. PMC: 2597791. DOI: 10.1038/sj.jid.5701132. View

11.

Adachi S, Yoshimura T, Matsuoka T, Okada K, Yasuda T, Kamei K . [Appearance of skin and nail toxicity in patients with breast cancer who underwent trastuzumab-containing chemotherapy]. Gan To Kagaku Ryoho. 2011; 38(9):1453-6. View

12.

Essler M, Ruoslahti E . Molecular specialization of breast vasculature: a breast-homing phage-displayed peptide binds to aminopeptidase P in breast vasculature. Proc Natl Acad Sci U S A. 2002; 99(4):2252-7. PMC: 122351. DOI: 10.1073/pnas.251687998. View

13.

Mahgoub I . Expression and characterization of a functional single-chain variable fragment (scFv) protein recognizing MCF7 breast cancer cells in E. coli cytoplasm. Biochem Genet. 2012; 50(7-8):625-41. DOI: 10.1007/s10528-012-9506-4. View

14.

HAMERS-CASTERMAN C, Atarhouch T, Muyldermans S, Robinson G, Hamers C, Songa E . Naturally occurring antibodies devoid of light chains. Nature. 1993; 363(6428):446-8. DOI: 10.1038/363446a0. View

15.

Newton J, Kelly K, Mahmood U, Weissleder R, Deutscher S . In vivo selection of phage for the optical imaging of PC-3 human prostate carcinoma in mice. Neoplasia. 2006; 8(9):772-80. PMC: 1584300. DOI: 10.1593/neo.06331. View

16.

Chahboun S, Hust M, Liu Y, Pelat T, Miethe S, Helmsing S . Isolation of a nanomolar scFv inhibiting the endopeptidase activity of botulinum toxin A, by single-round panning of an immune phage-displayed library of macaque origin. BMC Biotechnol. 2011; 11:113. PMC: 3252318. DOI: 10.1186/1472-6750-11-113. View

17.

Tang Y, Ning B, Cao J, Shen H, Qian B . Construction and expression of single-chain antibody derived from a new clone of monoclonal antibody against human CD14 in CHO cells. Immunopharmacol Immunotoxicol. 2007; 29(3-4):375-86. DOI: 10.1080/08923970701619927. View

18.

Emadi S, Liu R, Yuan B, Schulz P, McAllister C, Lyubchenko Y . Inhibiting aggregation of alpha-synuclein with human single chain antibody fragments. Biochemistry. 2004; 43(10):2871-8. DOI: 10.1021/bi036281f. View

19.

Markovic-Plese S, Hemmer B, Zhao Y, Simon R, Pinilla C, Martin R . High level of cross-reactivity in influenza virus hemagglutinin-specific CD4+ T-cell response: implications for the initiation of autoimmune response in multiple sclerosis. J Neuroimmunol. 2005; 169(1-2):31-8. DOI: 10.1016/j.jneuroim.2005.07.014. View

20.

Edwards W, Xu B, Akers W, Cheney P, Liang K, Rogers B . Agonist-antagonist dilemma in molecular imaging: evaluation of a monomolecular multimodal imaging agent for the somatostatin receptor. Bioconjug Chem. 2007; 19(1):192-200. PMC: 2539107. DOI: 10.1021/bc700291m. View